Evelien Kruisselbrink

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis

Johanna F. Dekkers, Gitte Berkers, Evelien Kruisselbrink et al. · Science Translational Medicine · 2016 · 549 citations

Medicine, Pharmacology, Clinical Pharmacology +8

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Gitte Berkers, Peter van Mourik, Annelotte M. Vonk et al. · Cell Reports · 2019 · 310 citations · Full text

Medicine, Cell Biology, Pharmacology +16

CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank

Maarten H. Geurts, Eyleen de Poel, Gimano D. Amatngalim et al. · Cell stem cell · 2020 · 220 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Mutagenic Capacity of Endogenous G4 DNA Underlies Genome Instability in FANCJ-Defective C. elegans

Evelien Kruisselbrink, Victor Guryev, Karin Brouwer et al. · Current Biology · 2008 · 210 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Protocol for Application, Standardization and Validation of the Forskolin-Induced Swelling Assay in Cystic Fibrosis Human Colon Organoids

Annelotte M. Vonk, Peter van Mourik, Anabela S. Ramalho et al. · STAR Protocols · 2020 · 127 citations · Full text

Medicine, Cell Biology, Pharmacology +12